Adderall XR 20 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FPX3Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,380
Award facts
- Contract value 100% obligated
- $1,380.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,380.29 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract was awarded on a firm fixed-price basis with no set-aside designation, indicating full and open competition. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that extends through December 2031, serving as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, specializing in delivering a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The parent company, Cencora, Inc., maintains significant contractual relationships with federal agencies including the DLA and Department of Veterans Affairs, demonstrating established capability to fulfill government medical procurement requirements across multiple therapeutic domains. This particular order for a controlled substance medication reflects the ongoing demand for essential prescription pharmaceuticals within the military healthcare system and reinforces AmerisourceBergen's role as a key distributor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FPX3Q?
SPE2DR26FPX3Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FPX3Q worth?
The government has obligated $1,380 on SPE2DR26FPX3Q.
Is contract SPE2DR26FPX3Q an order under another contract?
Yes. SPE2DR26FPX3Q is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPX3Q competed?
The extent of competition for SPE2DR26FPX3Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award